Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 129

1.

Better understanding of the health care costs of lung cancer and the implications.

Leidl R, Wacker M, Schwarzkopf L.

Expert Rev Respir Med. 2016 Feb 26:1-3. [Epub ahead of print] No abstract available.

PMID:
26916972
2.

Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study.

Wacker ME, Jörres RA, Schulz H, Heinrich J, Karrasch S, Karch A, Koch A, Peters A, Leidl R, Vogelmeier C, Holle R; COSYCONET-Consortium.

Respir Med. 2016 Feb;111:39-46. doi: 10.1016/j.rmed.2015.12.001. Epub 2015 Dec 10.

PMID:
26725462
3.

Restoration of Endothelial Function in Pparα (-/-) Mice by Tempol.

Silswal N, Parelkar N, Andresen J, Wacker MJ.

PPAR Res. 2015;2015:728494. doi: 10.1155/2015/728494. Epub 2015 Nov 15.

4.

Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry.

Kreuter M, Herth FJ, Wacker M, Leidl R, Hellmann A, Pfeifer M, Behr J, Witt S, Kauschka D, Mall M, Günther A, Markart P.

Biomed Res Int. 2015;2015:123876. doi: 10.1155/2015/123876. Epub 2015 Nov 10.

5.

Patient Heterogeneity In Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (Copd): are Current Models Suitable to Evaluate Personalized Medicine.

Hoogendoorn M, Feenstra T, Asukai Y, Briggs A, Borg S, Dal Negro R, Hansen RN, Jansson S, Wacker M, Risebrough N, Samyshkin Y, Leidl R, Rutten van-Mölken M.

Value Health. 2015 Nov;18(7):A694. doi: 10.1016/j.jval.2015.09.2586. Epub 2015 Oct 20. No abstract available.

PMID:
26533890
6.

Cost-components of lung cancer care within the first three years after initial diagnosis in context of different treatment regimens.

Schwarzkopf L, Wacker M, Holle R, Leidl R, Günster C, Adler JB, Huber RM.

Lung Cancer. 2015 Nov;90(2):274-80. doi: 10.1016/j.lungcan.2015.09.005. Epub 2015 Sep 10.

PMID:
26384433
7.

Invasive Squamous Cell Carcinoma in a Sternotomy Incision.

Wacker M, Fries JW, Rahmanian P, Wahlers T.

J Card Surg. 2015 Nov;30(11):820-1. doi: 10.1111/jocs.12635. Epub 2015 Sep 11. No abstract available.

PMID:
26358927
8.

Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli.

Ravenscroft N, Haeuptle MA, Kowarik M, Fernandez FS, Carranza P, Brunner A, Steffen M, Wetter M, Keller S, Ruch C, Wacker M.

Glycobiology. 2016 Jan;26(1):51-62. doi: 10.1093/glycob/cwv077. Epub 2015 Sep 9.

PMID:
26353918
9.

Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field.

Poolman JT, Wacker M.

J Infect Dis. 2016 Jan 1;213(1):6-13. doi: 10.1093/infdis/jiv429. Epub 2015 Sep 2. Review.

10.

Drug Release and Targeting: the Versatility of Polymethacrylate Nanoparticles for Peroral Administration Revealed by Using an Optimized In Vitro-Toolbox.

Beyer S, Moosmann A, Kahnt AS, Ulshöfer T, Parnham MJ, Ferreirós N, Wagner S, Wacker MG.

Pharm Res. 2015 Dec;32(12):3986-98. doi: 10.1007/s11095-015-1759-2. Epub 2015 Jul 28.

PMID:
26216175
11.

Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review.

Huber MB, Wacker ME, Vogelmeier CF, Leidl R.

PLoS One. 2015 Jul 13;10(7):e0132670. doi: 10.1371/journal.pone.0132670. eCollection 2015. Review.

12.

Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study.

Hatz CF, Bally B, Rohrer S, Steffen R, Kramme S, Siegrist CA, Wacker M, Alaimo C, Fonck VG.

Vaccine. 2015 Aug 26;33(36):4594-601. doi: 10.1016/j.vaccine.2015.06.102. Epub 2015 Jul 7.

PMID:
26162850
13.

The role of recent nanotechnology in enhancing the efficacy of radiation therapy.

Bergs JW, Wacker MG, Hehlgans S, Piiper A, Multhoff G, Rödel C, Rödel F.

Biochim Biophys Acta. 2015 Aug;1856(1):130-43. doi: 10.1016/j.bbcan.2015.06.008. Epub 2015 Jul 2. Review.

PMID:
26142869
14.

Nanocarriers for photodynamic therapy-rational formulation design and medium-scale manufacture.

Villa Nova M, Janas C, Schmidt M, Ulshoefer T, Gräfe S, Schiffmann S, de Bruin N, Wiehe A, Albrecht V, Parnham MJ, Luciano Bruschi M, Wacker MG.

Int J Pharm. 2015 Aug 1;491(1-2):250-60. doi: 10.1016/j.ijpharm.2015.06.024. Epub 2015 Jun 26.

PMID:
26123822
15.

A Systematic Approach to Identify Markers of Distinctly Activated Human Macrophages.

Sudan B, Wacker MA, Wilson ME, Graff JW.

Front Immunol. 2015 May 27;6:253. doi: 10.3389/fimmu.2015.00253. eCollection 2015.

16.

Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review.

Huber MB, Wacker ME, Vogelmeier CF, Leidl R.

PLoS One. 2015 Apr 13;10(4):e0123292. doi: 10.1371/journal.pone.0123292. eCollection 2015. Review.

17.

Assessing the drug release from nanoparticles: Overcoming the shortcomings of dialysis by using novel optical techniques and a mathematical model.

Xie L, Beyer S, Vogel V, Wacker MG, Mäntele W.

Int J Pharm. 2015 Jul 5;488(1-2):108-19. doi: 10.1016/j.ijpharm.2015.03.080. Epub 2015 Apr 4.

PMID:
25847513
18.

Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.

Ihssen J, Haas J, Kowarik M, Wiesli L, Wacker M, Schwede T, Thöny-Meyer L.

Open Biol. 2015 Apr;5(4):140227. doi: 10.1098/rsob.140227.

19.

Matching Pursuit-Based Time-Variant Bispectral Analysis and its Application to Biomedical Signals.

Schiecke K, Wacker M, Benninger F, Feucht M, Leistritz L, Witte H.

IEEE Trans Biomed Eng. 2015 Aug;62(8):1937-48. doi: 10.1109/TBME.2015.2407573. Epub 2015 Feb 26.

PMID:
25730821
20.

Advantages of signal-adaptive approaches for the nonlinear, time-variant analysis of heart rate variability of children with temporal lobe epilepsy.

Schiecke K, Wacker M, Benninger F, Feucht M, Leistritz L, Witte H.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:6377-80. doi: 10.1109/EMBC.2014.6945087.

PMID:
25571455
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk